Pfizer denies Ranbaxy buyout talk

Pfizer said it isn't buying a majority stake in Ranbaxy Laboratories, quashing rumors that it might counter Daiichi Sankyo's bid for the Indian drugmaker. "I can tell you that we have no intention of buying the company," a spokesman told Dow Jones. Report